acetyl l-carnitine when to take Designs for Health Acetyl L-Carnitine

Whats considered low can vary slightly between laboratories and practitioners, but general guidelines are: Standard reference ranges: Normal range: 5-15 mol/L (though this is quite broad) Low homocysteine: Below 5 mol/L Very low homocysteine: Below 3-4 mol/L Functional medicine optimal ranges: Many integrative and functional medicine practitioners use tighter ranges: Optimal: 6-9 mol/L Low-normal: 5-6 mol/L (may be fine if asymptomatic) Low: Below 5 mol/L (warrants investigation) Concerning: Below 3 mol/L (definitely needs evaluation) Context matters: Whether your homocysteine level is too low depends on several factors: You may be fine with low-normal levels (5-6 mol/L) if: You have no symptoms You eat adequate protein Your B-vitamin levels are good You have no chronic health issues You feel energetic and healthy Low levels (below 5 mol/L) may be concerning if: You have chronic fatigue or low energy You experience frequent infections or poor immunity You have signs of oxidative stress (inflammation, pain, skin issues) Youre dealing with chronic illness You have multiple chemical sensitivities You follow a very low protein or vegan diet You have unexplained symptoms Age and gender considerations: Homocysteine levels naturally vary by: Age tends to increase slightly with age Gender men typically have slightly higher levels than women Pregnancy levels often drop during pregnancy (this is normal) Menopause levels may increase after menopause When to test: Homocysteine testing is typically done: Fasting (8-12 hours without food) for most accurate results In the morning when possible Before starting B-vitamin supplementation (if you want baseline levels) Alongside B12, folate, and other relevant markers The bottom line: Homocysteine below 5 mol/L is generally considered low, and levels below 3-4 mol/L warrant investigation, especially if you have symptoms

Now in the 70s with a daily supplement

Epidemiological data consistently links elevated IGF-1 to increased cancer risk

Dasgupta, S., Hoque, M

PLoS Genet, 2016